Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-DLL3 antibodies and drug conjugates for use in melanoma

Anti-DLL3 antibodies and drug conjugates for use in melanoma

US Patent 10308721 · Granted Jun 4, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric receptors and methods of use thereof2024
Light chain variable regions2021
Anti-BMPR1B antibodies and methods of use2021
Anti-BMPR1B antibodies and methods of use2021
Anti SEZ6 antibodies and methods of use2020
Anti-MFI2 antibodies and methods of use2019
Anti-MFI2 antibodies and methods of use2019
Anti-DPEP3 antibodies and methods of use2019
Anti-DLL3 antibody drug conjugates for treating cancer2018
Anti-claudin antibodies and methods of use2018
SEZ6 modulators and methods of use2018
Anti-DLL3 antibody drug conjugates and methods of use2018